Temodar and Pancreatitis - a phase IV clinical study of FDA data

Summary:

Pancreatitis is reported as a side effect among people who take Temodar (temozolomide), especially for people who are female, 30-39 old, have been taking the drug for 6 - 12 months also take Prilosec, and have Glioblastoma.

The phase IV clinical study analyzes which people have Pancreatitis when taking Temodar. It is created by eHealthMe based on reports of 6,563 people who have side effects when taking Temodar from the FDA, and is updated regularly.

What is Temodar?

Temodar has active ingredients of temozolomide. It is often used in glioblastoma multiforme. eHealthMe is studying from 6,683 Temodar users. Check the latest studies of Temodar.

What is Pancreatitis?

Pancreatitis (inflammation of pancreas) is found to be associated with 1,765 drugs and 2,025 conditions by eHealthMe. Check the latest studies of Pancreatitis.

On Jul, 21, 2026

6,563 people reported to have side effects when taking Temodar.
Among them, 20 people (0.3%) have Pancreatitis.

Among these 20 people:

How long have people been on Temodar when they have Pancreatitis? *

What is the gender of people who have Pancreatitis when taking Temodar? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Pancreatitis when taking Temodar? *

What are other drugs people take besides Temodar? *

What are other side effects people have besides Pancreatitis? *

Dehydration (dryness resulting from the removal of water): 8 people, 40.00%
Back Pain: 6 people, 30.00%
Device Related Infection: 6 people, 30.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 6 people, 30.00%
Candidiasis (candidiasis or thrush is a fungal infection): 6 people, 30.00%
Abdominal Pain: 4 people, 20.00%
White Blood Cell Count Increased: 2 people, 10.00%
Hypotension (abnormally low blood pressure): 2 people, 10.00%
Bacterial Infection: 2 people, 10.00%
Flatulence (flatus expelled through the anus): 2 people, 10.00%

What are the existing conditions these people have? *

Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 6 people, 30.00%
Metastases To Central Nervous System (cancer spreads to central nervous system): 1 person, 5.00%
Malignant Melanoma (skin cancer rises from melancytes): 1 person, 5.00%
Glioma (a type of tumour that starts in the brain or spine): 1 person, 5.00%
Brain Stem Glioma (cancerous glioma tumour in the brainstem): 1 person, 5.00%
Birth Control: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Temodar and have Pancreatitis?

- Check whether Pancreatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Temodar:

Temodar (6,683 reports)

Pancreatitis treatments and more:

Pancreatitis (62,704 reports)

Browse all side effects of Temodar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pancreatitis:

Pancreatitis (1,765 drugs)

Browse all the conditions that are associated with Pancreatitis:

Pancreatitis (2,025 conditions)

Related publications that referenced our studies

Sirkeci, ?., Sirkeci, E. E., & Ta?el, B. , "Rivaroxaban-induced acute pancreatitis", The European Research Journal, 2018 Jan .
Liao, K. F., Huang, P. T., Lin, C. C., Lin, C. L., & Lai, S. W., "Fluvastatin use and risk of acute pancreatitis: a population-based case-control study in Taiwan", Biomedicine, 2014 Jan .
Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .
Sirkeci, ?., Sirkeci, E. E., & Ta?el, B. , "Rivaroxaban-induced acute pancreatitis", The European Research Journal, 2018 Jan .
Liao, K. F., Huang, P. T., Lin, C. C., Lin, C. L., & Lai, S. W., "Fluvastatin use and risk of acute pancreatitis: a population-based case-control study in Taiwan", Biomedicine, 2014 Jan .
Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .

How the study uses the data?

The study uses data from the FDA. It is based on temozolomide (the active ingredients of Temodar) and Temodar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.